Category: Finance
-

Spin-Off Gains Seed Funds for Non-Opioid Pain Drug
A company spun-off from a university medical materials lab received start-up funds to develop a non-opioid surgical pain therapy, including a clinical trial.
-

Start-up Funds Univ. Medical Cannabis Research
A developer of therapies derived from cannabis is sponsoring a 3-year basic and translational research program, including clinical trials, at Imperial College London.
-

Lilly Buys Precision Cancer Company in $8B Deal
Drug maker Eli Lilly and Company is acquiring a developer of cancer therapies that target specific genetic alterations rather than tumors in the body.
-

Infographic – Nasdaq Biotech Index Recovers
We’ll check in from time to time on the Nasdaq Biotechnology Index that tracks 223 biotech industry stocks.
-

Govt. Shutdown Disrupts U.S. Science
Several agencies that run or finance labs are closed, due to the lapse of funding for about a quarter of federal departments that began on 22 December.
-

Infographic – Tech IPOs Flat in 2018
CB Insights recently issued its annual Tech IPO Report, showing the number of initial public stock offerings in the technology industries unchanged from 2017.
-

Drug Discovery Start-Up Gains $400M Financing
A 2 year-old company using computational techniques to find protein-targeting drugs raised $400 million in new financing, led by the venture funding arm of Softbank.
-

Chip Device to Test Gut Infections on Space Station
A device with human intestine tissue and cells will be launched into space to test effects of weightlessness on immune functions and bacterial infections in the gastrointestinal tract.
-

Virtual Reality Illness Fix in Development
A computer science and engineering team in Texas is developing a technical solution for virtual reality experiences that can make some users physically ill, with symptoms like seasickness.
-

Nanotech Gene Therapy Company Raises $8.5M in Seed Funds
A start-up company developing nanoscale particles to deliver gene-editing enzymes, including those for Crispr, is raising $8.5 million in its seed funding round.